TuHURA Biosciences, Inc. Common Stock

HURANASDAQUSD
2.24 USD
0.02 (1.08%)🟢PRE MARKET (AS OF 04:12 AM EDT)
🟢Market: OPEN
Open?$2.27
High?$2.27
Low?$2.20
Prev. Close?$2.22
Volume?27
Avg. Volume?1.2M
VWAP?$2.26
Rel. Volume?0.00x
Bid / Ask
Bid?$2.14 × 100
Ask?$2.23 × 100
Spread?$0.09
Midpoint?$2.19
Valuation & Ratios
Market Cap?141.1M
Shares Out?N/A
Float?32.2M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?6.74
EPS?-$0.47
Dividend?0.01%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.78Weak
Quick Ratio?0.78Weak
Cash Ratio?0.61Adequate
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
6.74FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-4.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-143.6%WEAK
ROA?
-109.9%WEAK
Cash Flow & Enterprise
FCF?$-27705233
Enterprise Value?$137.7M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Employees
22
Market Cap
149.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-10-18
Address
10500 UNIVERSITY CENTER DR.
TAMPA, FL 33612
Phone: 813-875-6600